Cerebellar dysfunction in multiple sclerosis: evidence for an acquired channelopathy

Area of Science:

• Neuroscience
• Neuroimmunology
• Channelopathies

Background:

• Cerebellar dysfunction significantly contributes to disability in multiple sclerosis (MS).
• Current symptomatic therapies are often ineffective, and disease-modifying agents do not halt progression.
• Understanding the pathophysiology of MS-related cerebellar deficits is crucial.

Purpose of the Study:

• To review evidence suggesting abnormal sodium channel expression in Purkinje cells contributes to cerebellar dysfunction in MS.
• To investigate the role of sodium channel Na(v)1.8 in Purkinje cell electrogenesis in the context of MS.

Main Methods:

• Review of existing literature on Purkinje cell function and sodium channel expression in MS.
• Analysis of Na(v)1.8 mRNA and protein expression in Purkinje cells from MS models (EAE) and human postmortem tissue.
• In vitro and in vivo electrophysiological recordings of Purkinje cells.

Main Results:

• Sodium channel Na(v)1.8, normally absent in Purkinje cells, is expressed in both MS models and human MS tissue.
• In vitro, Na(v)1.8 expression alters Purkinje cell electrogenesis, increasing action potential duration/amplitude and altering firing patterns.
• In vivo recordings from EAE mice show similar electrophysiological changes in Purkinje cells.

Conclusions:

• Aberrant expression of sodium channel Na(v)1.8 in Purkinje cells is implicated in cerebellar dysfunction in MS.
• This mis-tuning of Purkinje cells distorts their normal firing patterns, contributing to MS-related neurological deficits.